The final testing work has been designed to ensure that the new integrated clinical information system is robust, fit for purpose and adheres to safety and quality guidelines.
Clinical design teams at CST, including hundreds of highly-skilled, multi-disciplinary professionals from across VCH, PHSA and PHC, have been designing our future clinical workflows, based on leading practices. In doing so, they have also been defining the requirements for our new clinical information system.
Once the clinical requirements have been finalized and validated, the final testing begins. Clinical design team members who have already been engaged in design decisions will take part in four levels of testing:
The teams will test the system using clinical scenarios based on approved design decisions. Test cases and scenarios will help ensure that patient safety is not jeopardized by the implementation of the clinical information system. Some examples of this are:
- Placing an order for a drug in the penicillin family when a patient has a documented allergy to penicillin.
- Placing an order for acetaminophen when a patient has already received the maximum daily acetaminophen dose.
- Placing more than one order for different forms of insulin.
- Placing an order for the same medication twice, once as an IV medication and once as an oral medication.
- Input of high risk medication (by nurse or MD through telephone/verbal order workflow) and availability of order for administration without pharmacy verification.
Test cases and scenarios will also show that patient safety is improved by the implementation of the clinical information system. Some examples of this are screening tools and alerts that reduce the incidence of such adverse events as:
- Medication administration errors
- Urinary tract infections
- Pressure ulcers
- Hospital-acquired pneumonia
- Overuse of antibiotics